MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617011796 A) filed by Duke Street Bio Limited, London, on Feb. 4, for 'deuterated parp1 inhibitor compounds.'
Inventor(s) include Cowley, Phillip; and Wise, Alan.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "A PARP1 inhibitor compound has a structure: Formula (I) Z1, Z2, and Z3 are each selected from C and N. R1 and R2 together form a 5- or 6-membered ring or are each independently absent or an organic group. R3 is absent or an organic group. R4 is an organic group. L has a structure: Formula (II). Each X2 is selected from C, N, O and S. n is 1 or 2; m is (3-n); p is 1, 2, or 3; q is (4-p); r is 1, 2, or 3; s is (4-r). Rings A and B are non-aromatic. Ring C is aromatic. Each R5A group is independently absent; a member of a pair of R5A groups which together form a bridging group; or an organic group. Each R5B and R5C is independently absent or an organic group. The compound is useful in medicine, e.g. for the treatment of cancer."
The patent application was internationally filed on July 17, 2024, under International application No.PCT/EP2024/070317.
Disclaimer: Curated by HT Syndication.
